Exlinkibart Biosimilar - Research Grade

Human

TNFRSF9ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q07011

Blue ice

4-1BB/CD137 (TNFRSF9) is a costimulatory receptor on activated T and NK cells that amplifies effector function and survival. Built around TNFRSF9, this research-grade anti-human recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of exlinkibart intended for research use only (RUO). It is manufactured to demanding in vivo standards as an ultra-pure, low-endotoxin formulation and supplied in scalable milligram (mg) to gram (g) quantities to meet the throughput needs of heavy-usage laboratories. The antibody supports costimulatory agonist and receptor-binding assays, in vitro T-cell activation screening, in vivo tumor immunology models, and biologics characterization as a dependable reference reagent.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks